Emerging benefits of Fc fusion technology in the context of recombinant factor VIII replacement therapy.
Saved in:
| Title: | Emerging benefits of Fc fusion technology in the context of recombinant factor VIII replacement therapy. |
|---|---|
| Authors: | Meeks SL; Aflac Cancer Center and Blood Disorders Center at Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA., Lacroix-Desmazes S; Centre de recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France. |
| Source: | Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2020 Nov; Vol. 26 (6), pp. 958-965. Date of Electronic Publication: 2020 Sep 03. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2516 (Electronic) Linking ISSN: 13518216 NLM ISO Abbreviation: Haemophilia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1365-2516 |
|---|---|
| DOI: | 10.1111/hae.14123 |
